ZA200908202B - A medicament comprising a carbostyril derivates and donepezil for treating alzheimer's disease - Google Patents

A medicament comprising a carbostyril derivates and donepezil for treating alzheimer's disease

Info

Publication number
ZA200908202B
ZA200908202B ZA200908202A ZA200908202A ZA200908202B ZA 200908202 B ZA200908202 B ZA 200908202B ZA 200908202 A ZA200908202 A ZA 200908202A ZA 200908202 A ZA200908202 A ZA 200908202A ZA 200908202 B ZA200908202 B ZA 200908202B
Authority
ZA
South Africa
Prior art keywords
carbostyril
donepezil
derivates
medicament
disease
Prior art date
Application number
ZA200908202A
Other languages
English (en)
Inventor
Heii Arai
Original Assignee
Otsuka Pharma Co Ltd
Univ Juntendo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd, Univ Juntendo filed Critical Otsuka Pharma Co Ltd
Publication of ZA200908202B publication Critical patent/ZA200908202B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200908202A 2007-05-22 2009-11-20 A medicament comprising a carbostyril derivates and donepezil for treating alzheimer's disease ZA200908202B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007135367 2007-05-22

Publications (1)

Publication Number Publication Date
ZA200908202B true ZA200908202B (en) 2010-07-28

Family

ID=39636992

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200908202A ZA200908202B (en) 2007-05-22 2009-11-20 A medicament comprising a carbostyril derivates and donepezil for treating alzheimer's disease

Country Status (28)

Country Link
US (1) US20100298375A1 (fr)
EP (2) EP2937085B1 (fr)
JP (1) JP5153870B2 (fr)
KR (1) KR101441725B1 (fr)
CN (1) CN101754758B (fr)
AR (1) AR066664A1 (fr)
AU (1) AU2008253977B2 (fr)
BR (1) BRPI0811919A2 (fr)
CA (1) CA2687289C (fr)
CO (1) CO6251249A2 (fr)
CY (1) CY1116683T1 (fr)
DK (1) DK2157973T3 (fr)
ES (1) ES2545959T3 (fr)
HK (2) HK1140422A1 (fr)
HR (1) HRP20150843T1 (fr)
HU (1) HUE025902T2 (fr)
IL (1) IL202053A (fr)
MX (1) MX2009012583A (fr)
MY (1) MY146407A (fr)
NZ (1) NZ581099A (fr)
PL (1) PL2157973T3 (fr)
PT (1) PT2157973E (fr)
RU (1) RU2469723C2 (fr)
SI (1) SI2157973T1 (fr)
TW (2) TWI423802B (fr)
UA (1) UA96633C2 (fr)
WO (1) WO2008143361A1 (fr)
ZA (1) ZA200908202B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2135607A1 (fr) 2008-06-18 2009-12-23 Pharnext Combinaison de pilocarpine et methimazol pour le traitement de la maladie de Charcot-MarieTooth et des troubles associés
US9387206B2 (en) 2009-11-03 2016-07-12 Pharnext Therapeutic approaches for treating Alzheimer's disease
EP2322163A1 (fr) 2009-11-03 2011-05-18 Pharnext Nouvelles approches thérapeutiques pour traiter la maladie d'Alzheimer
US9248111B2 (en) 2011-03-01 2016-02-02 Pharnext Therapeutic approaches for treating parkinson's disease
US10010515B2 (en) 2011-03-01 2018-07-03 Pharnext Therapeutic approaches for treating Parkinson's disease
PL2727588T3 (pl) 2011-03-01 2019-04-30 Pharnext Terapia zaburzeń neurologicznych oparta na baklofenie i akamprozacie
US9241933B2 (en) 2011-03-01 2016-01-26 Pharnext Compositions for treating amyotrophic lateral sclerosis
JP5715303B2 (ja) * 2012-06-15 2015-05-07 公益財団法人先端医療振興財団 軽度認知障害の予防および／または治療剤
WO2015100255A2 (fr) * 2013-12-23 2015-07-02 Holaday John W Récipient jetable pour hydratation de l'air
US20190142820A1 (en) 2016-05-19 2019-05-16 National Cerebral And Cardiovascular Center Drug for preventing and/or treating dementia
DK3630098T3 (da) 2017-05-24 2021-04-26 H Lundbeck As Kombination af en 5-ht6-receptorantagonist og en acetylcholinsteraseinhibitor til anvendelse i behandlingen af alzheimers sygdom hos en patientsubpopulation som har apoe4-alleller
CN107602523B (zh) * 2017-09-11 2020-08-18 安徽中医药大学 京尼平类似物、制备方法及其应用
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
NL2024431B1 (en) 2019-12-11 2021-09-07 Sulfateq Bv Compounds for treatment of alzheimer’s disease

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535019A (en) 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPS5649378A (en) 1979-08-25 1981-05-02 Otsuka Pharmaceut Co Ltd Tetrazolylalkoxycarbostyril derivative
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
JP2574099B2 (ja) 1992-05-21 1997-01-22 大塚製薬株式会社 アレルギー疾患治療剤
JPH10175864A (ja) 1996-12-16 1998-06-30 Otsuka Pharmaceut Co Ltd 慢性閉塞性肺疾患治療剤
US6019735A (en) * 1997-08-28 2000-02-01 Visco Technologies, Inc. Viscosity measuring apparatus and method of use
US6322524B1 (en) * 1997-08-28 2001-11-27 Visco Technologies, Inc. Dual riser/single capillary viscometer
US6322525B1 (en) * 1997-08-28 2001-11-27 Visco Technologies, Inc. Method of analyzing data from a circulating blood viscometer for determining absolute and effective blood viscosity
US6428488B1 (en) * 1997-08-28 2002-08-06 Kenneth Kensey Dual riser/dual capillary viscometer for newtonian and non-newtonian fluids
ES2237078T3 (es) * 1998-01-16 2005-07-16 Eisai Co., Ltd. Procedimiento para producir derivados de donepezilo.
US6187790B1 (en) * 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6484565B2 (en) * 1999-11-12 2002-11-26 Drexel University Single riser/single capillary viscometer using mass detection or column height detection
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
TW200301135A (en) * 2001-12-27 2003-07-01 Otsuka Maryland Res Inst Inc Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
IL150509A (en) * 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
US6743806B2 (en) * 2002-10-23 2004-06-01 Otsuka Pharmaceutical Company, Limited Active oxygen scavenger
FR2848452B1 (fr) * 2002-12-12 2007-04-06 Aventis Pharma Sa Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer
JP2004189706A (ja) * 2002-12-13 2004-07-08 Eisai Co Ltd 高度アルツハイマー型痴呆治療剤
TWI323660B (en) * 2003-02-25 2010-04-21 Otsuka Pharma Co Ltd Pten inhibitor or maxi-k channels opener

Also Published As

Publication number Publication date
PL2157973T3 (pl) 2015-12-31
EP2937085A1 (fr) 2015-10-28
KR101441725B1 (ko) 2014-09-18
AU2008253977B2 (en) 2013-08-22
UA96633C2 (uk) 2011-11-25
ES2545959T3 (es) 2015-09-17
CN101754758A (zh) 2010-06-23
MY146407A (en) 2012-08-15
KR20100020482A (ko) 2010-02-22
CY1116683T1 (el) 2017-03-15
CN101754758B (zh) 2012-10-24
IL202053A (en) 2016-04-21
IL202053A0 (en) 2010-06-16
EP2157973B1 (fr) 2015-07-15
AU2008253977A1 (en) 2008-11-27
JP5153870B2 (ja) 2013-02-27
NZ581099A (en) 2012-03-30
SI2157973T1 (sl) 2015-10-30
MX2009012583A (es) 2010-03-08
CO6251249A2 (es) 2011-02-21
WO2008143361A1 (fr) 2008-11-27
HK1140422A1 (en) 2010-10-15
DK2157973T3 (en) 2015-08-17
TWI489983B (zh) 2015-07-01
RU2469723C2 (ru) 2012-12-20
JP2010527993A (ja) 2010-08-19
US20100298375A1 (en) 2010-11-25
TW201412315A (zh) 2014-04-01
BRPI0811919A2 (pt) 2014-11-18
TWI423802B (zh) 2014-01-21
PT2157973E (pt) 2015-10-14
HUE025902T2 (en) 2016-05-30
TW200904428A (en) 2009-02-01
HK1215384A1 (zh) 2016-08-26
HRP20150843T1 (hr) 2015-09-11
AR066664A1 (es) 2009-09-02
CA2687289A1 (fr) 2008-11-27
EP2157973A1 (fr) 2010-03-03
EP2937085B1 (fr) 2019-07-10
CA2687289C (fr) 2015-09-15
RU2009147456A (ru) 2011-06-27

Similar Documents

Publication Publication Date Title
ZA200908202B (en) A medicament comprising a carbostyril derivates and donepezil for treating alzheimer's disease
EP2091566A4 (fr) Traitements par combinaison pour la maladie d'alzheimer et des maladies analogues
IL195668A0 (en) Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
IL195574A0 (en) Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
PL1993365T3 (pl) Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem
EP2011513A4 (fr) Agents thérapeutiques employés dans le cadre de la maladie d'alzheimer et du cancer
ZA201007460B (en) Use of epothelone in treating tau-associated disease including alzheimer's disease
IL209894A (en) Compounds for the prevention and / or treatment of β-amyloidosis including Alzheimer's disease
PL1868623T3 (pl) Zastosowanie LGG w wytwarzaniu leku do zapobiegania lub leczenia alergii oddechowych
ZA200810528B (en) Procedure and methods for detecting Alzheimer's disease
EP2485733A4 (fr) Procédés pour le traitement de la maladie d'alzheimer
EP2306824A4 (fr) Administration par ionophorèse de curcumine et analogues de curcumine destinés au traitement de la maladie d'alzheimer
EP2231180A4 (fr) Vaccin contre la maladie d'alzheimer
ZA201101752B (en) A medicinal product and treatment
EP2375895A4 (fr) Méthode de traitement de la maladie d'alzheimer et d'états apparentés
EP2005964A4 (fr) Médicament pour traiter l'hyperphosphatémie et son procédé de préparation
EP2565184B8 (fr) Agent thérapeutique et agent préventiv contre la maladie d'alzheimer
EP2305629A4 (fr) Agent thérapeutique pour la maladie d'alzheimer
EP2174666A4 (fr) Agent médicamenteux pour la prévention ou le traitement de la maladie d'alzheimer
EP2099476A4 (fr) Procédés de traitement de maladie d'alzheimer
HUP0600409A3 (en) Izatin and it's derivatives for use as a medicine
TWI341204B (en) Composition and method for prevention and treatment of alzheimer's disease
IL214340A0 (en) Methods and compositions for treating alzheimer's disease
AU2007902117A0 (en) A drug for the treatment of Alzheimer?s disease
GB0811555D0 (en) Treatment of Alzheimer's disease